WO2014095959A1 - Membrane construction with fiber layers for blood filtration - Google Patents
Membrane construction with fiber layers for blood filtration Download PDFInfo
- Publication number
- WO2014095959A1 WO2014095959A1 PCT/EP2013/077030 EP2013077030W WO2014095959A1 WO 2014095959 A1 WO2014095959 A1 WO 2014095959A1 EP 2013077030 W EP2013077030 W EP 2013077030W WO 2014095959 A1 WO2014095959 A1 WO 2014095959A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- support layer
- membrane
- membrane construction
- nanoweb
- range
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 86
- 238000010276 construction Methods 0.000 title claims abstract description 62
- 210000004369 blood Anatomy 0.000 title claims description 27
- 239000008280 blood Substances 0.000 title claims description 27
- 238000001914 filtration Methods 0.000 title claims description 12
- 239000000835 fiber Substances 0.000 title description 7
- 239000002121 nanofiber Substances 0.000 claims abstract description 56
- 239000011148 porous material Substances 0.000 claims abstract description 36
- 210000002381 plasma Anatomy 0.000 claims abstract description 23
- 238000000926 separation method Methods 0.000 claims abstract description 11
- 210000000601 blood cell Anatomy 0.000 claims abstract description 7
- 239000004952 Polyamide Substances 0.000 claims description 27
- 229920002647 polyamide Polymers 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 18
- 239000011521 glass Substances 0.000 claims description 3
- 229920001410 Microfiber Polymers 0.000 claims description 2
- 239000003658 microfiber Substances 0.000 claims description 2
- 238000004626 scanning electron microscopy Methods 0.000 claims 1
- 229920000642 polymer Polymers 0.000 description 25
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- -1 poly(vinylchlorides) Polymers 0.000 description 10
- 229920002292 Nylon 6 Polymers 0.000 description 9
- 238000001523 electrospinning Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000009987 spinning Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000004953 Aliphatic polyamide Substances 0.000 description 6
- 229920002302 Nylon 6,6 Polymers 0.000 description 6
- 229920003231 aliphatic polyamide Polymers 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 229920003235 aromatic polyamide Polymers 0.000 description 6
- 229920006150 hyperbranched polyester Polymers 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000004744 fabric Substances 0.000 description 5
- 239000012982 microporous membrane Substances 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 229920000098 polyolefin Polymers 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 229920006012 semi-aromatic polyamide Polymers 0.000 description 4
- 239000004760 aramid Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000003490 calendering Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920001007 Nylon 4 Polymers 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 230000003373 anti-fouling effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229940090045 cartridge Drugs 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229920006345 thermoplastic polyamide Polymers 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- AQQSXKSWTNWXKR-UHFFFAOYSA-N 2-(2-phenylphenanthro[9,10-d]imidazol-3-yl)acetic acid Chemical compound C1(=CC=CC=C1)C1=NC2=C(N1CC(=O)O)C1=CC=CC=C1C=1C=CC=CC=12 AQQSXKSWTNWXKR-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101001067833 Homo sapiens Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 229920000784 Nomex Polymers 0.000 description 1
- 229920003188 Nylon 3 Polymers 0.000 description 1
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 1
- 125000000641 acridinyl group Chemical class C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 229920000587 hyperbranched polymer Polymers 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000004750 melt-blown nonwoven Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000004763 nomex Substances 0.000 description 1
- 229920006111 poly(hexamethylene terephthalamide) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920003366 poly(p-phenylene terephthalamide) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000412 polyarylene Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 108010094020 polyglycine Proteins 0.000 description 1
- 229920000232 polyglycine polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000010069 protein adhesion Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 150000003334 secondary amides Chemical class 0.000 description 1
- 229920006114 semi-crystalline semi-aromatic polyamide Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/10—Supported membranes; Membrane supports
- B01D69/107—Organic support material
- B01D69/1071—Woven, non-woven or net mesh
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
- B01D39/16—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
- B01D39/1607—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous
- B01D39/1623—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous of synthetic origin
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4374—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece using different kinds of webs, e.g. by layering webs
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3633—Blood component filters, e.g. leukocyte filters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/02—Types of fibres, filaments or particles, self-supporting or supported materials
- B01D2239/025—Types of fibres, filaments or particles, self-supporting or supported materials comprising nanofibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/06—Filter cloth, e.g. knitted, woven non-woven; self-supported material
- B01D2239/065—More than one layer present in the filtering material
- B01D2239/0654—Support layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/12—Special parameters characterising the filtering material
- B01D2239/1233—Fibre diameter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
- B01D71/04—Glass
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/56—Polyamides, e.g. polyester-amides
Definitions
- the invention relates to a membrane construction for the separation of blood cells from blood plasma, a membrane cassette comprising said membrane construction, a device comprising said membrane construction or said membrane cassette and the uses thereof such as for example blood filtration, diagnostic devices, bio-separation of cell cultures and bio-fermentation.
- the invention relates in particular to a membrane for a point of care (POC) device.
- POC devices will enable patients to monitor themselves with a few drops of blood and communicate results with clinicians, ultimately giving patients a greater control of their own health and access to their personal health data.
- POC devices may also support the emergence of personalized medicine in which treatments are tailored to the genetic profile of patients and/or to their specific metabolism of drugs.
- a POC device is attractive because it requires only a few microliter of blood from a patient.
- red blood cells RBC's
- Hct red blood cells
- human blood with a volume percentage of RBC's (the hematocrit or Hct) of between 35 and 55 vol% may quickly block a filter, which implies an undesirably long time to separate RBC's form the plasma.
- Separation of blood and plasma has to be done within about 300 seconds in order to avoid hemolysis of RBC's. With hemolysis, the plasma loses its quality for a subsequent analysis, as protein recovery is poor.
- WO201 1 151314 describes a membrane construction comprising multiple layers wherein at least one of the layers is a nanoweb made of polymeric nanofibers, the mean flow pore size of the nanoweb is in the range from 50 nm to 5 ⁇ , the number average diameter of the nanofibers is in the range from 100 to 600 nm, the basis weight of the nanoweb is in the range from 1 to 20 g/m 2 , the porosity of the nanoweb is in the range from 60 to 95 %, at least one of the layers is a support layer and preferably but not necessarily the nanoweb is hydrophilic.
- WO201 1 151314 is, that the time to separate RBC's from plasma is too long, reason for which the blood has to be diluted first.
- An object of the present invention is to provide a membrane construction whereby time to separate plasma from RBC's in blood for small quantities, typically below 100 ⁇ , with an Hct of 55 vol% is below 300 seconds with good protein recovery.
- this object is achieved by the membrane construction for the separation of blood cells from blood plasma, comprising multiple layers wherein:
- - at least of the layers is a support layer
- At least one of the layers is a nanoweb made of polymeric nanofibers wherein the nanoweb comprises a mean flow pore size in the range from 0.3 to 3 ⁇ measured according to standard ASTM E 1294-89, a basis weight in the range 1 to 20 g/m 2 measured according to standard ASTM D 3776 and a porosity in the range from 60 to 95 % measured according to standard ASTM D 2873-94 and
- nanofibers have a number average diameter in the range from 100 to 600 nm;
- the support layer is a porous layer with a mean flow pore size of between 5 and 15 ⁇ and h.P.A 100 is more than 5 ⁇ _, wherein h is the thickness of the support layer, P the porosity (%) of the support layer and A the surface of the support layer in the membrane construction.
- the membrane construction according to the present invention provides good results when filtrating blood.
- the best results have been obtained when the thickness h in the range 200 to 400 ⁇ , the porosity P in the range 80% to 97% and the surface A is in the range 0.2 to 1.8 cm 2 ,
- a support layer being a porous layer with a mean flow pore size of between 5 and 15 ⁇ and a h.P.A/100 being more than 5 ⁇ _
- RBC's can be separated from plasma in less than 100 sec with good protein recovery.
- h.P.A/100 is more than 15 ⁇ _ in order to ensure an optimum separation.
- membrane construction is meant a collection of layers together forming the membrane construction.
- 'multiple layers' is meant at least two layers. Each of the layers differ in mean flow pore size and/or type of material.
- a membrane construction comprising multiple layers
- multiple layers can be made using phase inversion (e.g. as described in US6045899) or for example by spinning the nanoweb on the same place while moving the support layer or vice versa, moving the spinning head above a fixed support layer, or by laminating the support layer with the nanoweb.
- phase inversion e.g. as described in US6045899
- hot laminating may be used and/or glue may for example be applied onto the support material and/or the support layer may be in a hot-melt state when the nanoweb is applied thereon.
- nanoweb made of polymeric nanofibers is meant a nonwoven web comprising primarily, or even exclusively polymeric nanofibers.
- the mean flow pore size of the nanoweb is in the range from 0.3 to
- the mean flow pore size is determined according to standard ASTM E 1294-89, "standard test method for pore size characteristics of membrane filters using automated liquid porosimeter” by using automated bubble point method from ASTM designation F 316 using a capillary flow porosimeter (model number CFP-34RTF8A-3-6-L4, Porous Materials, Inc. (PMI), Ithaca, N.Y.).
- the mean flow pore size can also be advantageously measured indirectly with airflow techniques via the air permeability, such as Gurley or Airflux.
- the measuring area can be reduced, for example to 1 cm 2 , and the volume of air to be permeated can be increased, for example 100 ml or 200 ml, to thus allowing the permeation time to be measured more accurately.
- the thus obtained measuring values can be recalculated to the corresponding value for the standard measuring set up, and also these modifications can be applied in accordance with ISO 5636-5.
- the relation between the Gurley (50 cc) number and air permeability is described in ISO 5636-5.
- the air permeability measured with Gurley, and expressed in s/50ml, can be translated via an empirical relation into pore size in ⁇ , by dividing the number 1 ,77 by the Gurley number.
- the mean flow pore size of the nanoweb is at least 0.3, for example at least 0.4, for example at least 0.5 ⁇ .
- the at least 0.3 urn mean flow pore size provides a good flux into the membrane and reduces residence time, thereby limiting protein adsorption at the surface of the membrane construction.
- a maximum of 1.5 urn mean flow pore size allows an optimal filtration by removing the suitable components of the blood (such red blood cells).
- the mean flow pore size is at most 0.9, for example at most 0.8, for example at most 0.7 ⁇ .
- the preferred range of the nanoweb is between 0.4 and 1 .5 ⁇ , providing the best results in blood filtration.
- the mean flow pore size of the nanoweb may be reduced by calendering the nanoweb and/or the nanoweb in combination with the support layer. This may increase the strength of the nanoweb and/or the nanoweb in combination with the support layer.
- Calendering is the process of passing sheet material (in this case the nanoweb) through a nip between rolls or plates. The calendering process also affects the porosity P and the thickness h of the support, and the resulting values need to match the previous requirements.
- the mean flow pore size (of the nanoweb) is influenced by a combination of the thickness of the nanoweb and the number average diameter of the nanofibers. For example, by increasing the thickness, the mean flow pore size may be reduced. By reducing the number average diameter of the nanofibers, the mean flow pore size can also be reduced.
- the mean flow pore size is defined by a thickness h in the range 200 to 400 ⁇ , a porosity P in the range 80% to 97% and surface A in the range 0.2 to 1.8 cm 2 .
- the basis weight of the nanoweb is in the range from 1 to 20 g/m 2 .
- the basis weight can be measured according to standard ASTM D-3776, which is hereby incorporated by reference.
- the basis weight of the nanoweb is in the range 2 to 6 g/m 2 .
- a nanofiber web may be prepared from nanofibers using methods known to the person skilled in the art, for example via multi-nozzle electrospinning, for example as described in WO2005/073441 , hereby incorporated by reference; via nozzle-free electrospinning, for example using a NanopiderTM apparatus, bubble- spinning or the like; or via electroblowing, for example as described in WO03/080905, hereby incorporated by reference; via melt-blowing or via centriguge-spinning.
- the desired basis weight can be achieved by adjusting the flow rate of an electrospinning process using to spin the nanofiber and/or by adjusting the speed of the support layer onto which the nanoweb is spun.
- the porosity of the nanoweb is in the range from 60 to 95%.
- the porosity of the nanoweb is the difference between 100% and the solidity of the nanoweb.
- Porosity 100% - % solidity. Porosity is determined according to standard ASTM D 2873-94, or by standard ASTM F 2450-10 which methods are hereby incorporated by reference.
- the porosity of the nanoweb is in the range from 60 to 95%, for example the porosity of the nanoweb is for example at least 65%, for example at least 70%, for example at least 80%.
- Sample thickness is determined by ASTM D-645 (or ISO 534), which method is hereby incorporated by reference, under an applied load of 50kPa and an anvil surface area of 200mm 2 .
- the density (p) of the polymer composition is measured as described in IS01 183-1 :2004.
- the surface A of the filter in the membrane construction for example any filtration device, such as a cartridge.
- Polymer density is measured as described in IS01 183-1 :2004.
- 'nanofibers' refers to fibers having a number average diameter of at most 10OOnm (1 ⁇ ).
- the number average diameter of the nanofibers present in the membrane construction according to the present invention is in the range 100 to 600 nm, preferably the number average diameter of the nanofibers is at most 500 nm, more preferably at most 400 nm.
- the number average diameter of the nanofibers is at least 150, more advantageously, at least 200nm.
- the membrane construction presents a minimized clogging and/or an optimal flux and/or an efficient filtration (which can also be designated as optimal retention of the particulate to be filtrated).
- the nanofiber diameter can be reduced e.g. reducing the solution concentration, reducing the polymer molecular weight, or modifying the process conditions (applied voltage, solution flow rate, spinning distance).
- the desired number average diameter of the nanofiber can be achieved by routine experimentation. Factors that may influence the number average diameter of the nanofiber are the viscosity of the polymer solution used to make the nanofibers (usually between 200 and l OOOmPa.s), the electrical voltage, the flow rate of the polymer solution and the choice of polymer.
- the polymeric nanofiber may be prepared from any polymer material.
- polymer materials include but are not limited to polyacetals, polyamides, polyesters, polyolefins, cellulose ethers and esters, polyalkylene sulfides, polyarylene oxides, polysulfones, modified polysulfone polymers and mixtures thereof. Examples of materials that fall within these generic classes include poly(vinylchlorides),
- the membrane shows less clogging of the material to be filtrated than with other polymers.
- Good results in blood filtration have been obtained when the polymeric nanofiber is prepared from a polyamide chosen from the group of aromatic polyamides, semi-aromatic polyamides, aliphatic polyamides, mixtures and copolyamides thereof, Preferably the polyamide is from the group of aliphatic polyamides, mixtures and copolyamides thereof.
- Aliphatic polyamides are preferred over aromatic and semi-aromatic polyamides when used for electrospinning of the nanofibers since aromatic and semi- aromatic polyamides usually require more hazardous solvents or from a
- the polyamides may be crystalline, semi-crystalline or amorphous.
- the polymeric nanofiber is prepared from a semi-crystalline polyamide.
- semi-aromatic polyamides include terephthalic acid based polyamides, for example polyamide 4,T polyamide 6,T/6,6, polyamide 4,10, polyamide 9,T, polyamide 6T/6I or PAMXD,6, PAMXDT or copolyamides thereof;
- aromatic polyamides also known as polyaramides, for example
- polyparaphyleneterephthalamide (PPTA, commercially available as for example KevlarTM, TwaronTM or TechnoraTM) or polyparaphyleneisophthalamide (PPIA, commercially available as Nomex ); aliphatic polyamides, for example polyamide 2 (polyglycine), polyamide-3, polyamide-4, polyamide-5, polyamide-6, polyamide-2,6, polyamide-2,8, polyamide-6,6, polyamide-4,6 or polyamide 6,10 or copolyamides thereof, for example polyamide 6/6,6, polyamide 4,6/6; or copolyamides of semi- aromatic and/or aromatic and/or aliphatic polyamides.
- aliphatic polyamides for example polyamide 2 (polyglycine), polyamide-3, polyamide-4, polyamide-5, polyamide-6, polyamide-2,6, polyamide-2,8, polyamide-6,6, polyamide-4,6 or polyamide 6,10 or copolyamides thereof, for example polyamide 6/6,6, polyamide 4,6/6; or copolyamide
- thermoplastic polyamides include but are not limited to polyamide 6; polyamide 6,6; polyamide 4,6; polyamide 4,10; polyamide 6,10;
- the nanoweb may have a high wettability and a high (tensile) strength.
- Wettability (with a liquid of choice for example blood or water) of the base material of the nanoweb can be determined by measuring the advanced contact angle according to ASTM D7334-08 (using said liquid of choice). The lower the advanced contact angle of the nanoweb with said liquid of choice, the higher the wettability of the nanoweb.
- the wettability should be chosen such that the nanoweb can be impregnated with water and blood.
- Tensile strength can be measured on a tensile tester (Zwick) at a constant rate of elongation of 2 inches per minute. Samples are cut to a size of 1 inchx8inches, being longer in the direction of loading. The gage length of samples was 6 inches and the starting width of samples was 1 inch. The tensile strength is defined as the maximum load supported by a sample piece of the nanoweb divided by its cross-sectional area. Samples are tested in both the X (length) and the Y (width) direction.
- the polyamide has a carbon/nitrogen (C/N) ratio of at most
- the polyamide has a C/N ratio in the range of from 4-8.
- the nanofibers are prepared from polyamide-6, polyamide- 6,6, polyamide-4,6 or copolymers thereof, more preferably from polyamide-4,6.
- Polyamide-4,6 is a class of polyamides commercially available under the trademark StanylTM from DSM, the Netherlands.
- An advantage of the use of polyamide-6, polyamide-6,6, polyamide-4,6 or copolymers thereof and in particular of polyamide-4,6 to prepare the nanofibers may be an improved hydrophilicity of the nanoweb, which makes the nanoweb even more suitable for the uses described herein. Furthermore, advantages may be improved tensile strength and/or an increased thermal stability .
- polyamide encompasses for example polyamides comprising proteins such as for example silk or keratin as well as modified polyamides, such as for example hindered phenol end capped polyamides.
- additives may be present.
- Suitable additives include but are not limited to: surface tension agents or surfactants, for example perfluorinated acridine, crosslinking agents, viscosity modifiers, for example hyperbranched polymers such as hydroxylfunctional hyperbranched polyester amide polymers as described in WO1999/016810, carboxyfunctional hyperbranched polyester amide polymers as described in WO2000/056804, dialkylamide functional hyperbranched polyester amide polymers as described in WO2000/058388, ethoxyfunctional hyperbranched polyester amide polymers as described in WO2003/037959, heterofunctionalized hyperbranched polyester amides as described in WO2007/098889 or secondary amide hyperbranched polyester amides as described in WO2007/144189, electrolytes, antimicrobial additives, adhesion improvers, for example maleic acid anhydride grafted rubber or other additives to improve adhesion with WO2007/144189
- electrolytes antimicrobial additives
- electrolytes examples include water soluble metal salts, for example metal alkali metal salts, earth alkali metal salts and zinc salts, LiCI, HCOOK (potassium formate), CaCI 2 , ZnCI 2 , Kl 3 , Nal 3 .
- an electrolyte is present in an amount in the range of from 0 to 2 wt% relative to the total weight of the polymer solution.
- the water soluble salt may be extracted with water from the nanofibers produced, thereby obtaining microporous nanofibers.
- Nanofibers may be prepared using methods known to the skilled person, for example, they may be produced using electrospinning, such as classical electrospinning or electroblowing, and sometimes also by meltblowing processes.
- electrospinning such as classical electrospinning or electroblowing, and sometimes also by meltblowing processes.
- Classical electrospinning is illustrated in US 4,127,706, hereby incorporated by reference.
- Electrospinning, as well as centrifuge spinning, can operate from solutions or from melts.
- the preparation of nanofibers using an electrospinning process comprising the steps of:
- jet streams are being deposited on or taken up by the collector or a support layer
- the polymer in the jet stream solidifies prior to or while being deposited on or taken up by the collector or the support layer whereby the nanofibers are formed.
- the nanofibers may be post- stretched, post-coated, washed, dried, cured, annealed and/or post condensed. It may be advantageous to dry the nanofibers to remove residual solvents which may interfere with the analysis of the blood plasma obtained after filtration using the membrane construction of the invention.
- polyamide-4,6 nanofibers may be prepared by Huang, C. et al., 'Electrospun polymer nanofibres with small diameters', Nanotechnology, vol. 17 (2006), pp2558-2563.
- Hydrophilicity respectively hydrophobicity of a surface can be determined via the advanced contact angle made by a liquid, for example water using ASTM D7334-08. If the surface, for example the nanoweb shows an advanced contact angle with water of at least 90°, the surface, for example the nanoweb is defined herein as hydrophobic, if the surface, for example the nanoweb shows an advanced contact angle with water of less than 90°, the surface is defined herein as hydrophilic.
- the nanoweb is hydrophilic, more preferably, the nanoweb has a contact angle as measured with water using ASTM D7334-08 of less than 80°, for example less than 70°, for example less than 60°, for example less than 50°, for example less than 45°.
- the hydrophilicity of the nanoweb should be chosen such that the nanoweb can be impregnated with water and blood.
- the membrane construction of the invention comprises at least one support layer.
- the support layer is a porous layer with a mean flow pore size of between 5 and 15 ⁇ and h.P.A 100 is more than 5 ⁇ _, wherein h is the thickness of the support layer, P the porosity (%) of the support layer and A the surface of the support layer in the membrane construction (i.e. A is the top surface of the support layer).
- the support layer is a non-woven. With a non-woven, an
- h.P.A/100 is more than 15 ⁇ _.
- h.P.A/100 is at most 200 ⁇ _.
- the membrane construction comprises more than one support layer, wherein the support layers form a gradient pore structure.
- gradient pore structure is meant that the mean flow pore size in the membrane construction increases with the distance to the top layer of the membrane construction, e.g. the nanoweb.
- the sum of h.P.A/100 for the different layers should be more than 5 ⁇ _, preferably even more than 10 ⁇ _.
- h.P.A/100 is less than 100 ⁇ _, more preferably less than 50 ⁇ _, as no blood will pass the membrane construction by gravity or capillairy forces only without an additional driving force like e.g. a vacuum or an extra pressure.
- the porosity of the support layer is preferably at least 50%, for example at least 60%, for example at least 70%, for example at least 80%, for example at least 90%. Preferably the porosity of the support layer is a least 92%.
- the support layer is preferably also hydrophilic because outstanding results have been obtained when combining at least one hydrophilic support layer and at least one layer being a nanoweb: the membrane construction comprising such a structure provide the advantage of less clogging and/or less adhesion of proteins in the membrane.
- the support layer may be prepared from hydrophilic materials or if the support layer is prepared from hydrophobic material, the support layer may be coated with a hydrophilic coating as described herein.
- the hydrophilic support layer has a contact angle as measured with water using ASTM D 7334-08 below 80°, preferably below 70°, more preferably below 60°, most preferably below 50°, even most preferably below 45°.
- the nanoweb is made of polymeric nanofibers comprising a polyamide such as defined in the context of the present invention, the improved properties of the membrane with respect to clogging and decreased protein adhesion even better.
- the membrane construction of the invention comprises at least one support layer.
- the support layer may be any substrate on which the nanoweb can be added, for example a non-woven cloth, any fibrous substrate, or a filter or membrane layer, for example a microporous membrane.
- non-woven cloths include for example a meltblown nonwoven cloth, needle-punched or spunlaced nonwoven cloth, woven cloth and knitted cloth.
- the membrane construction according to the present invention comprises a support layer which is a non-woven layer based on micro-fibers with a number average diameter between 1 to 10 ⁇ .
- the support layer can comprise micro-glass.
- any fibrous substrates include, paper, any fibrous substrate comprising selected from the group of materials comprising glass, silica, metals, ceramic, silicon carbide, carbon, boron, natural fibers such as cotton, wool hemp or flax, artificial fibers, such as viscose or cellulosic fibers, synthetic fibers, for example polyester, polyamides, polyacrylics, chlorofibers, polyolefines, synthetic rubbers, polyvinylalcohol, armaides, fluorofibers, phenolic.
- any fibrous substrate comprising selected from the group of materials comprising glass, silica, metals, ceramic, silicon carbide, carbon, boron, natural fibers such as cotton, wool hemp or flax, artificial fibers, such as viscose or cellulosic fibers, synthetic fibers, for example polyester, polyamides, polyacrylics, chlorofibers, polyolefines, synthetic rubbers, polyvinylalcohol, armaides, fluorofibers, phenolic.
- the membrane may be prepared from any polymer, for example a nylon, polyamides, pref aliphatic polyamides, for example polyamide 6, polyamide-4,6, copolymers or mixtures thereof., a polyolefin or a halogenated vinyl polymer, preferably from a polyolefin or polytetrafluoroethylene (PTFE), more preferably from a polyethylene (PE), most preferably from ultra high molecular weight polyethylene (UHMWPE), which has a weight average molecular weight (Mw) of at least 0.5 * 10 6 g/mol.
- PTFE polyolefin or polytetrafluoroethylene
- PE polyethylene
- UHMWPE ultra high molecular weight polyethylene
- Microporous membranes made from UHMWPE is for example available from Lydall, the
- microporous membranes made from highly stretched UHMWPE are used as microporous membrane.
- the amount of polyolefin or halogenated vinyl polymer present in the microporous membrane is for example at least 20wt%, for example at least 50wt% relative to the total weight of the microporous membrane.
- Microporous membranes may be prepared using methods known to the skilled person. For example in US 3,876,738 it is described that microporous films may be produced by a process of quenching a polymer solution cast in a quench bath containing a non-solvent system for the polymer to form micropores in the resulting polymer film. For example, US5693231 describes a process for the preparation of microporous nylon membranes, US5264165 describes a process for the preparation of polyamide-4,6 microporous membranes.
- the nanoweb and the support layer are in contact with one another, as this may provide mechanical support and/or a reduced amount of so-called 'dead volume', that is the amount of liquid to be separated that stays inside the membrane construction rather than flowing through.
- the basic weight of the support layer is in the range of from 5 to 400 g/m 2 , preferably 20 to 100 g/m 2 .
- the membrane construction may comprise further layers besides the nanoweb and the support layer. These layers may be layers to increase the separation of the components to be separated and/or to increase the tensile strength of the membrane construction.
- the membrane construction may further comprise, a 'functional' membrane layer, a further nanoweb layer, a textile
- microporous support layer is present in the membrane construction according to the invention.
- the textile layer may also be the support layer if no microporous support layer is present in the membrane construction of the invention. In that case, the textile layer and the nanoweb are preferably in contact with one another.
- the textile layer can for example be any non-woven support or any fibrous substrate as described above.
- a nanoweb is spun directly onto a support surface with a mean flow pore size of between 5 -15 ⁇ , then multiple nanowebs forming a nanofiber gradient may be used.
- WO2008/142023 A2 describes for example how to spin a multiple layer gradient nanoweb.
- a two layer nanoweb wherein for examples one layer is prepared from nanofibers having a number average diameter in the range of from 500 to 600 nm and the top layer is prepared from nanofibers having a number average diameter in the range of from 100 to 200 nm, may be used.
- two layers are preferably in contact with one another by being bonded, adhered or laminated together.
- At least one of the layers of the membrane construction is coated.
- 'coated' is meant that the at least one layer is contacted with a coating solution, such that the coating solution impregnates the layer.
- the nanoweb layer and/or the support layers and/or any other further layer of the membrane construction may be coated, or treated with antifouling e.g. PEG, proteins or amino acids.
- a coating may affects the porosity P and the thickness h of the support. Once coated, the membrane should pass the previous requirements in terms of pore size, porosity, thickness and weight per unit of surface.
- coating solutions include antifouling coating solutions, for example antibiofouling coating solutions such as for example described in
- At least one of the layers of the membrane construction is coated with an antibiofouling coating.
- an antibiofouling coating protein recovery in the blood plasma is increased. If the membrane construction is used for diagnostics, this will enhance the analysis resolution. If the membrane construction is used for dialysis, the efficiency of the dialysis will be increased.
- a description on how to impregnate a membrane layer is for example given in WO2009/063067.
- the invention relates to a membrane cassette comprising the membrane construction of the invention.
- membrane cassette is meant a construction (housing) containing one or more membrane constructions of the invention.
- the invention in another aspect, relates to a device comprising the membrane construction of or the membrane cassette of the invention.
- Such devices may be devices used in plasma and serum separation in for example diagnostics; pre-analytical systems, such as blood collection devices, for example tubes and capillaries), micro fluidic point of care biosensor or Dry Plasma Spots.
- a filter with a diameter of 10 mm is mounted on a card-ridge with a two-sided sticky tape (outer diameter 10 mm, inner diameter 8 mm).
- This card ridge is an injection moulded part comprising a filter mounting surface, a flow channel and a chamber R. The card ridge is horizontally positioned during the test.
- Plasma that has passed the filter drops on a round flat surface with a diameter of 8 mm, comprising 6 grooves of each 0.15 mm width and 0.02 mm deep, separating the surface in 6 equal radial parts.
- the center of said surface is connected with a channel with a length of 24 mm , a width of 0.6 mm and height of 0.08 mm. Via this channel, plasma that has passed the filter is guided to a chamber of 1 .6x1 .6 mm 2 and a height of 0.08 mm. Two drops of blood with a volume of 50 ⁇ _ and a Hct% as given in Table 1 are applied with an Eppendorf pipette on the filter.
- the Start Time is the time wherein the first liquid has passed the first 4 mm in the channel.
- the Fill Time is the time wherein the chamber R is completely filled with plasma.
- the Pall GF filter is a filter made from polyethersulfone with a thickness of 340 ⁇ and a variable pore size ranging from 80 ⁇ to 3 ⁇ .
- a Novatex support layer (non-woven PA66/PA6) with a thickness of 200 ⁇ and a PA nanoweb layer with a thickness of 10 ⁇ is used.
- the base weight of the layer of nanofibers is 2 g/m 2 .
- the Examples I to VII according to the invention are based on a Lypore 9858 PEG microglass support layer with a base weight of 49.5 g/m 2 (density 2.5 g/cm 3 ) and a PA 46, 70 ⁇ thick layer of nanofibers with a base weight of 2 g/m 2 .
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
The invention relates to a membrane construction for the separation of blood cells from blood plasma, comprising multiple layers wherein at least of the layers is a support layer; at least one of the layers is a nanoweb made of polymeric nanofibers wherein the nanoweb comprises a mean flow pore size in the range from 0.3 to 3 μm measured according to standard ASTM E 1294-89, a basis weight in the range 1 to 20 g/m2 measured according to standard ASTM D 3776 and a porosity in the range from 60 to 95 % measured according to standard ASTM D 2873-94; and wherein the nanofibers have a number average diameter in the range from 100 to 600 nm; characterised in that the support layer is a porous layer with a mean flow pore size of between 5 and 15 μm and h.P.A/100 is more than 5μL, wherein h is the thickness of the support layer, P the porosity (%) of the support layer and A the surface of the support layer in the membrane construction.
Description
MEMBRANE CONSTRUCTION WITH FIBER LAYERS FOR
BLOOD FILTRATION
The invention relates to a membrane construction for the separation of blood cells from blood plasma, a membrane cassette comprising said membrane construction, a device comprising said membrane construction or said membrane cassette and the uses thereof such as for example blood filtration, diagnostic devices, bio-separation of cell cultures and bio-fermentation. The invention relates in particular to a membrane for a point of care (POC) device. POC devices will enable patients to monitor themselves with a few drops of blood and communicate results with clinicians, ultimately giving patients a greater control of their own health and access to their personal health data. In addition, POC devices may also support the emergence of personalized medicine in which treatments are tailored to the genetic profile of patients and/or to their specific metabolism of drugs. A POC device is attractive because it requires only a few microliter of blood from a patient. To analyses proteins, related certain diseases in a patient's blood, red blood cells (RBC's) have to be separated from the plasma, which is generally done by filtration for small quantities of blood. However, human blood with a volume percentage of RBC's (the hematocrit or Hct) of between 35 and 55 vol% may quickly block a filter, which implies an undesirably long time to separate RBC's form the plasma. Separation of blood and plasma has to be done within about 300 seconds in order to avoid hemolysis of RBC's. With hemolysis, the plasma loses its quality for a subsequent analysis, as protein recovery is poor.
Membrane constructions for blood filtration are known from
WO201 1 151314. WO201 1 151314 describes a membrane construction comprising multiple layers wherein at least one of the layers is a nanoweb made of polymeric nanofibers, the mean flow pore size of the nanoweb is in the range from 50 nm to 5 μηι, the number average diameter of the nanofibers is in the range from 100 to 600 nm, the basis weight of the nanoweb is in the range from 1 to 20 g/m2, the porosity of the nanoweb is in the range from 60 to 95 %, at least one of the layers is a support layer and preferably but not necessarily the nanoweb is hydrophilic.
A disadvantage of the membrane construction described in
WO201 1 151314 is, that the time to separate RBC's from plasma is too long, reason for which the blood has to be diluted first.
An object of the present invention is to provide a membrane construction whereby time to separate plasma from RBC's in blood for small quantities, typically below 100 μί, with an Hct of 55 vol% is below 300 seconds with good protein
recovery.
According to the present invention, this object (amongst other objects), is achieved by the membrane construction for the separation of blood cells from blood plasma, comprising multiple layers wherein:
- at least of the layers is a support layer;
at least one of the layers is a nanoweb made of polymeric nanofibers wherein the nanoweb comprises a mean flow pore size in the range from 0.3 to 3 μηη measured according to standard ASTM E 1294-89, a basis weight in the range 1 to 20 g/m2 measured according to standard ASTM D 3776 and a porosity in the range from 60 to 95 % measured according to standard ASTM D 2873-94 and
wherein the nanofibers have a number average diameter in the range from 100 to 600 nm;
characterised in that the support layer is a porous layer with a mean flow pore size of between 5 and 15 μηη and h.P.A 100 is more than 5μΙ_, wherein h is the thickness of the support layer, P the porosity (%) of the support layer and A the surface of the support layer in the membrane construction.
Advantageously, when h.P.A 100 is more than 5μΙ_ and defined by a thickness h of about 250 μηη and a porosity P of at least 80%, the membrane construction according to the present invention provides good results when filtrating blood. The best results have been obtained when the thickness h in the range 200 to 400 μηη, the porosity P in the range 80% to 97% and the surface A is in the range 0.2 to 1.8 cm2,
As a result of a support layer being a porous layer with a mean flow pore size of between 5 and 15 μηη and a h.P.A/100 being more than 5μΙ_, with the membrane construction of the invention RBC's can be separated from plasma in less than 100 sec with good protein recovery. Preferably, h.P.A/100 is more than 15μΙ_ in order to ensure an optimum separation.
With membrane construction is meant a collection of layers together forming the membrane construction. With 'multiple layers' is meant at least two layers. Each of the layers differ in mean flow pore size and/or type of material.
It is known to the skilled person how to prepare a membrane construction comprising multiple layers, for example multiple layers can be made using phase inversion (e.g. as described in US6045899) or for example by spinning the nanoweb on the same place while moving the support layer or vice versa, moving the spinning head above a fixed support layer, or by laminating the support layer with the
nanoweb. In order to attach the nanoweb to the other layers, hot laminating may be used and/or glue may for example be applied onto the support material and/or the support layer may be in a hot-melt state when the nanoweb is applied thereon.
In the context of the invention, with nanoweb made of polymeric nanofibers is meant a nonwoven web comprising primarily, or even exclusively polymeric nanofibers.
The mean flow pore size of the nanoweb is in the range from 0.3 to
3 μηι.
In the context of the present invention, the mean flow pore size is determined according to standard ASTM E 1294-89, "standard test method for pore size characteristics of membrane filters using automated liquid porosimeter" by using automated bubble point method from ASTM designation F 316 using a capillary flow porosimeter (model number CFP-34RTF8A-3-6-L4, Porous Materials, Inc. (PMI), Ithaca, N.Y.).
The mean flow pore size can also be advantageously measured indirectly with airflow techniques via the air permeability, such as Gurley or Airflux. The method that is applied for the air permeability, and from which the values have been derived for mean flow pore size values reported herein, is the Gurley test method according to ISO 5636-5. As a standard measuring set up a measuring area of 6.45 cm2 and a load of 567 grams is used, and the time needed for 50 ml of air to be permeated is measured. The air permeability thus measured is expressed in s/50ml, (wherein s = seconds and ml = millilitre). For micro-porous membranes with relative large pore sizes, for example with a mean flow pore size of about 1 μηη or more, the measuring area can be reduced, for example to 1 cm2, and the volume of air to be permeated can be increased, for example 100 ml or 200 ml, to thus allowing the permeation time to be measured more accurately. The thus obtained measuring values can be recalculated to the corresponding value for the standard measuring set up, and also these modifications can be applied in accordance with ISO 5636-5. The relation between the Gurley (50 cc) number and air permeability is described in ISO 5636-5. The air permeability measured with Gurley, and expressed in s/50ml, can be translated via an empirical relation into pore size in μηη, by dividing the number 1 ,77 by the Gurley number.
Advantageously, the mean flow pore size of the nanoweb is at least 0.3, for example at least 0.4, for example at least 0.5 μηη. The at least 0.3 urn mean flow pore size provides a good flux into the membrane and reduces residence time,
thereby limiting protein adsorption at the surface of the membrane construction. A maximum of 1.5 urn mean flow pore size allows an optimal filtration by removing the suitable components of the blood (such red blood cells). For example, the mean flow pore size is at most 0.9, for example at most 0.8, for example at most 0.7 μηη. The preferred range of the nanoweb is between 0.4 and 1 .5 μηη, providing the best results in blood filtration.
The mean flow pore size of the nanoweb may be reduced by calendering the nanoweb and/or the nanoweb in combination with the support layer. This may increase the strength of the nanoweb and/or the nanoweb in combination with the support layer. Calendering is the process of passing sheet material (in this case the nanoweb) through a nip between rolls or plates. The calendering process also affects the porosity P and the thickness h of the support, and the resulting values need to match the previous requirements.
The mean flow pore size (of the nanoweb) is influenced by a combination of the thickness of the nanoweb and the number average diameter of the nanofibers. For example, by increasing the thickness, the mean flow pore size may be reduced. By reducing the number average diameter of the nanofibers, the mean flow pore size can also be reduced.
In the context of the present invention, the mean flow pore size is defined by a thickness h in the range 200 to 400 μηη, a porosity P in the range 80% to 97% and surface A in the range 0.2 to 1.8 cm2.
With 'basis weight of the nanoweb' is meant the weight per square meter. The basis weight of the nanoweb is in the range from 1 to 20 g/m2. The basis weight can be measured according to standard ASTM D-3776, which is hereby incorporated by reference. Preferably, the basis weight of the nanoweb is in the range 2 to 6 g/m2.
A nanofiber web may be prepared from nanofibers using methods known to the person skilled in the art, for example via multi-nozzle electrospinning, for example as described in WO2005/073441 , hereby incorporated by reference; via nozzle-free electrospinning, for example using a Nanopider™ apparatus, bubble- spinning or the like; or via electroblowing, for example as described in WO03/080905, hereby incorporated by reference; via melt-blowing or via centriguge-spinning.
The desired basis weight can be achieved by adjusting the flow rate of an electrospinning process using to spin the nanofiber and/or by adjusting the speed of the support layer onto which the nanoweb is spun.
The porosity of the nanoweb is in the range from 60 to 95%. The porosity of the nanoweb is the difference between 100% and the solidity of the nanoweb. The solidity can be calculated by dividing the basis weight of the nanoweb sample in g/m2, determined as described herein, by the polymer density of the polymer from which the nanofiber is made in g/cm3 and by the sample thickness in μηη and multiplying by 100, i.e. solidity = (basis weight/(density*thickness)) *100. Porosity = 100% - % solidity. Porosity is determined according to standard ASTM D 2873-94, or by standard ASTM F 2450-10 which methods are hereby incorporated by reference.
The porosity of the nanoweb is in the range from 60 to 95%, for example the porosity of the nanoweb is for example at least 65%, for example at least 70%, for example at least 80%.
Sample thickness is determined by ASTM D-645 (or ISO 534), which method is hereby incorporated by reference, under an applied load of 50kPa and an anvil surface area of 200mm2. The density (p) of the polymer composition is measured as described in IS01 183-1 :2004.
The surface A of the filter in the membrane construction, for example any filtration device, such as a cartridge.
Polymer density is measured as described in IS01 183-1 :2004.
The term 'nanofibers', as used herein, refers to fibers having a number average diameter of at most 10OOnm (1 μηη).
To determine the number average diameter of the fibers, ten (10) scanning electron microscopy (SEM) images at 5,000x magnification were taken of each nanofiber sample or web layer thereof. The diameter of ten (10 clearly distinguishable nanofibers was measured from each photograph and recorded, resulting in a total of one hundred (100) individual measurements. Defects were not included (i.e. lumps of nanofibers, polymer drops, intersections of nanofibers). The number average diameter d of the fibers was calculated from the one hundred (100) individual measurements.
Preferably, the number average diameter of the nanofibers present in the membrane construction according to the present invention is in the range 100 to 600 nm, preferably the number average diameter of the nanofibers is at most 500 nm, more preferably at most 400 nm. Advantageously, the number average diameter of the nanofibers is at least 150, more advantageously, at least 200nm. When the number average diameter of the nanofibers is in the range 200 nm to 400 nm, preferably 200- 300 nm, the membrane construction presents a minimized clogging and/or an optimal
flux and/or an efficient filtration (which can also be designated as optimal retention of the particulate to be filtrated).
The nanofiber diameter can be reduced e.g. reducing the solution concentration, reducing the polymer molecular weight, or modifying the process conditions (applied voltage, solution flow rate, spinning distance).
The desired number average diameter of the nanofiber can be achieved by routine experimentation. Factors that may influence the number average diameter of the nanofiber are the viscosity of the polymer solution used to make the nanofibers (usually between 200 and l OOOmPa.s), the electrical voltage, the flow rate of the polymer solution and the choice of polymer.
The polymeric nanofiber may be prepared from any polymer material. Examples of polymer materials include but are not limited to polyacetals, polyamides, polyesters, polyolefins, cellulose ethers and esters, polyalkylene sulfides, polyarylene oxides, polysulfones, modified polysulfone polymers and mixtures thereof. Examples of materials that fall within these generic classes include poly(vinylchlorides),
polymethylmethacrylates and other acrylic resins, polystyrenes and copolymers thereof, for example ABA type block copolymers, poly(vinylidene fluorides), poly(vinylidene chlorides), polyvinylalcohols.
When the polymeric nanofiber is made of polyamide, the membrane shows less clogging of the material to be filtrated than with other polymers. Good results in blood filtration have been obtained when the polymeric nanofiber is prepared from a polyamide chosen from the group of aromatic polyamides, semi-aromatic polyamides, aliphatic polyamides, mixtures and copolyamides thereof, Preferably the polyamide is from the group of aliphatic polyamides, mixtures and copolyamides thereof. Aliphatic polyamides are preferred over aromatic and semi-aromatic polyamides when used for electrospinning of the nanofibers since aromatic and semi- aromatic polyamides usually require more hazardous solvents or from a
polyvinylalcohol. The polyamides may be crystalline, semi-crystalline or amorphous. Preferably, the polymeric nanofiber is prepared from a semi-crystalline polyamide.
Examples of semi-aromatic polyamides, include terephthalic acid based polyamides, for example polyamide 4,T polyamide 6,T/6,6, polyamide 4,10, polyamide 9,T, polyamide 6T/6I or PAMXD,6, PAMXDT or copolyamides thereof;
aromatic polyamides, also known as polyaramides, for example
polyparaphyleneterephthalamide (PPTA, commercially available as for example Kevlar™, Twaron™ or Technora™) or polyparaphyleneisophthalamide (PPIA,
commercially available as Nomex ); aliphatic polyamides, for example polyamide 2 (polyglycine), polyamide-3, polyamide-4, polyamide-5, polyamide-6, polyamide-2,6, polyamide-2,8, polyamide-6,6, polyamide-4,6 or polyamide 6,10 or copolyamides thereof, for example polyamide 6/6,6, polyamide 4,6/6; or copolyamides of semi- aromatic and/or aromatic and/or aliphatic polyamides.
Preferred thermoplastic polyamides include but are not limited to polyamide 6; polyamide 6,6; polyamide 4,6; polyamide 4,10; polyamide 6,10;
polyamide 4,6, copolyamides and/or mixtures thereof, more preferably polyamide-6, polyamide 4,6, copolyamides and/or mixtures thereof. If the nanoweb is made from nanofibers made from these preferred thermoplastic polyamides, the nanoweb may have a high wettability and a high (tensile) strength.
Wettability (with a liquid of choice for example blood or water) of the base material of the nanoweb can be determined by measuring the advanced contact angle according to ASTM D7334-08 (using said liquid of choice). The lower the advanced contact angle of the nanoweb with said liquid of choice, the higher the wettability of the nanoweb. The wettability should be chosen such that the nanoweb can be impregnated with water and blood.
Tensile strength can be measured on a tensile tester (Zwick) at a constant rate of elongation of 2 inches per minute. Samples are cut to a size of 1 inchx8inches, being longer in the direction of loading. The gage length of samples was 6 inches and the starting width of samples was 1 inch. The tensile strength is defined as the maximum load supported by a sample piece of the nanoweb divided by its cross-sectional area. Samples are tested in both the X (length) and the Y (width) direction.
Preferably, the polyamide has a carbon/nitrogen (C/N) ratio of at most
9, more preferably, the polyamide has a C/N ratio in the range of from 4-8.
Preferably, the nanofibers are prepared from polyamide-6, polyamide- 6,6, polyamide-4,6 or copolymers thereof, more preferably from polyamide-4,6.
Polyamide-4,6 is a class of polyamides commercially available under the trademark Stanyl™ from DSM, the Netherlands. An advantage of the use of polyamide-6, polyamide-6,6, polyamide-4,6 or copolymers thereof and in particular of polyamide-4,6 to prepare the nanofibers may be an improved hydrophilicity of the nanoweb, which makes the nanoweb even more suitable for the uses described herein. Furthermore, advantages may be improved tensile strength and/or an increased thermal stability .
As used herein, the term polyamide encompasses for example
polyamides comprising proteins such as for example silk or keratin as well as modified polyamides, such as for example hindered phenol end capped polyamides.
In the polymer solution comprising the polymeric material of choice used to prepare the nanofibers, additives may be present. Suitable additives include but are not limited to: surface tension agents or surfactants, for example perfluorinated acridine, crosslinking agents, viscosity modifiers, for example hyperbranched polymers such as hydroxylfunctional hyperbranched polyester amide polymers as described in WO1999/016810, carboxyfunctional hyperbranched polyester amide polymers as described in WO2000/056804, dialkylamide functional hyperbranched polyester amide polymers as described in WO2000/058388, ethoxyfunctional hyperbranched polyester amide polymers as described in WO2003/037959, heterofunctionalized hyperbranched polyester amides as described in WO2007/098889 or secondary amide hyperbranched polyester amides as described in WO2007/144189, electrolytes, antimicrobial additives, adhesion improvers, for example maleic acid anhydride grafted rubber or other additives to improve adhesion with a polypropylene or polyethylene terephthalate substrate, nanoparticles, for example nanotubes or nanoclays, and so on. Examples of electrolytes include water soluble metal salts, for example metal alkali metal salts, earth alkali metal salts and zinc salts, LiCI, HCOOK (potassium formate), CaCI2, ZnCI2, Kl3, Nal3. Preferably, an electrolyte is present in an amount in the range of from 0 to 2 wt% relative to the total weight of the polymer solution. The water soluble salt may be extracted with water from the nanofibers produced, thereby obtaining microporous nanofibers.
Nanofibers may be prepared using methods known to the skilled person, for example, they may be produced using electrospinning, such as classical electrospinning or electroblowing, and sometimes also by meltblowing processes. Classical electrospinning is illustrated in US 4,127,706, hereby incorporated by reference. Electrospinning, as well as centrifuge spinning, can operate from solutions or from melts.
The preparation of nanofibers using an electrospinning process comprising the steps of:
applying a high voltage between a spinneret comprising a series of spinning nozzles and a collector, or between a separate electrode and a collector feeding a stream of polymer solution comprising a polymer and a solvent, or a polymer melt, to the spinneret
whereby the polymeric solution or melt exits from the spinneret through the spinning nozzles and transforms under the influence of the high voltage into charged jet streams,
whereby the jet streams are being deposited on or taken up by the collector or a support layer
whereby the polymer in the jet stream solidifies prior to or while being deposited on or taken up by the collector or the support layer whereby the nanofibers are formed.
After preparation of the nanofibers, the nanofibers may be post- stretched, post-coated, washed, dried, cured, annealed and/or post condensed. It may be advantageous to dry the nanofibers to remove residual solvents which may interfere with the analysis of the blood plasma obtained after filtration using the membrane construction of the invention.
A detailed description on how polyamide-4,6 nanofibers may be prepared is for example given by Huang, C. et al., 'Electrospun polymer nanofibres with small diameters', Nanotechnology, vol. 17 (2006), pp2558-2563.
Hydrophilicity respectively hydrophobicity of a surface can be determined via the advanced contact angle made by a liquid, for example water using ASTM D7334-08. If the surface, for example the nanoweb shows an advanced contact angle with water of at least 90°, the surface, for example the nanoweb is defined herein as hydrophobic, if the surface, for example the nanoweb shows an advanced contact angle with water of less than 90°, the surface is defined herein as hydrophilic.
Preferably, the nanoweb is hydrophilic, more preferably, the nanoweb has a contact angle as measured with water using ASTM D7334-08 of less than 80°, for example less than 70°, for example less than 60°, for example less than 50°, for example less than 45°. The hydrophilicity of the nanoweb should be chosen such that the nanoweb can be impregnated with water and blood.
The membrane construction of the invention comprises at least one support layer. The support layer is a porous layer with a mean flow pore size of between 5 and 15 μηη and h.P.A 100 is more than 5μΙ_, wherein h is the thickness of the support layer, P the porosity (%) of the support layer and A the surface of the support layer in the membrane construction (i.e. A is the top surface of the support layer). Preferably, the support layer is a non-woven. With a non-woven, an
advantageously high porosity can be obtained.
Surprisingly only for a membrane construction with a support layer
with a mean flow pore size between 5 μηι and 15 μηι, preferably between 5 μηι and 10 μηι and with h.P.A 100 being more than 5 μΙ_, the time to separate RBC's from plasma is less than 100 sec. Preferably, h.P.A/100 is more than 15 μΙ_. Advantageously, h.P.A/100 is at most 200 μΙ_.
In a special embodiment, the membrane construction comprises more than one support layer, wherein the support layers form a gradient pore structure. With 'gradient pore structure' is meant that the mean flow pore size in the membrane construction increases with the distance to the top layer of the membrane construction, e.g. the nanoweb. In that case, the sum of h.P.A/100 for the different layers should be more than 5 μΙ_, preferably even more than 10 μΙ_. Preferably h.P.A/100 is less than 100 μΙ_, more preferably less than 50 μΙ_, as no blood will pass the membrane construction by gravity or capillairy forces only without an additional driving force like e.g. a vacuum or an extra pressure.
The porosity of the support layer is preferably at least 50%, for example at least 60%, for example at least 70%, for example at least 80%, for example at least 90%. Preferably the porosity of the support layer is a least 92%.
The support layer is preferably also hydrophilic because outstanding results have been obtained when combining at least one hydrophilic support layer and at least one layer being a nanoweb: the membrane construction comprising such a structure provide the advantage of less clogging and/or less adhesion of proteins in the membrane. The support layer may be prepared from hydrophilic materials or if the support layer is prepared from hydrophobic material, the support layer may be coated with a hydrophilic coating as described herein.
More preferably, the hydrophilic support layer has a contact angle as measured with water using ASTM D 7334-08 below 80°, preferably below 70°, more preferably below 60°, most preferably below 50°, even most preferably below 45°. When the nanoweb is made of polymeric nanofibers comprising a polyamide such as defined in the context of the present invention, the improved properties of the membrane with respect to clogging and decreased protein adhesion even better.
The membrane construction of the invention comprises at least one support layer. The support layer may be any substrate on which the nanoweb can be added, for example a non-woven cloth, any fibrous substrate, or a filter or membrane layer, for example a microporous membrane. Examples of non-woven cloths include for example a meltblown nonwoven cloth, needle-punched or spunlaced nonwoven cloth,
woven cloth and knitted cloth. Preferably, the membrane construction according to the present invention comprises a support layer which is a non-woven layer based on micro-fibers with a number average diameter between 1 to 10 μηη.
According to an embodiment of the present invention, the support layer can comprise micro-glass.
Examples of any fibrous substrates include, paper, any fibrous substrate comprising selected from the group of materials comprising glass, silica, metals, ceramic, silicon carbide, carbon, boron, natural fibers such as cotton, wool hemp or flax, artificial fibers, such as viscose or cellulosic fibers, synthetic fibers, for example polyester, polyamides, polyacrylics, chlorofibers, polyolefines, synthetic rubbers, polyvinylalcohol, armaides, fluorofibers, phenolic.
If a microporous membrane is used as the at least one support layer, the membrane may be prepared from any polymer, for example a nylon, polyamides, pref aliphatic polyamides, for example polyamide 6, polyamide-4,6, copolymers or mixtures thereof., a polyolefin or a halogenated vinyl polymer, preferably from a polyolefin or polytetrafluoroethylene (PTFE), more preferably from a polyethylene (PE), most preferably from ultra high molecular weight polyethylene (UHMWPE), which has a weight average molecular weight (Mw) of at least 0.5*106 g/mol. Microporous membranes made from UHMWPE is for example available from Lydall, the
Netherlands under the name Solupor™. Preferably, microporous membranes made from highly stretched UHMWPE are used as microporous membrane.
The amount of polyolefin or halogenated vinyl polymer present in the microporous membrane is for example at least 20wt%, for example at least 50wt% relative to the total weight of the microporous membrane.
Microporous membranes may be prepared using methods known to the skilled person. For example in US 3,876,738 it is described that microporous films may be produced by a process of quenching a polymer solution cast in a quench bath containing a non-solvent system for the polymer to form micropores in the resulting polymer film. For example, US5693231 describes a process for the preparation of microporous nylon membranes, US5264165 describes a process for the preparation of polyamide-4,6 microporous membranes.
Preferably, the nanoweb and the support layer are in contact with one another, as this may provide mechanical support and/or a reduced amount of so-called 'dead volume', that is the amount of liquid to be separated that stays inside the membrane construction rather than flowing through.
The basic weight of the support layer is in the range of from 5 to 400 g/m2, preferably 20 to 100 g/m2.
The membrane construction may comprise further layers besides the nanoweb and the support layer. These layers may be layers to increase the separation of the components to be separated and/or to increase the tensile strength of the membrane construction. For example, the membrane construction may further comprise, a 'functional' membrane layer, a further nanoweb layer, a textile
layer.etc.This textile layer is preferably in contact with the support layer if a
microporous support layer is present in the membrane construction according to the invention. The textile layer may also be the support layer if no microporous support layer is present in the membrane construction of the invention. In that case, the textile layer and the nanoweb are preferably in contact with one another.
The textile layer can for example be any non-woven support or any fibrous substrate as described above.
In case a nanoweb is spun directly onto a support surface with a mean flow pore size of between 5 -15 μηη, then multiple nanowebs forming a nanofiber gradient may be used. WO2008/142023 A2 describes for example how to spin a multiple layer gradient nanoweb. For instance, a two layer nanoweb, wherein for examples one layer is prepared from nanofibers having a number average diameter in the range of from 500 to 600 nm and the top layer is prepared from nanofibers having a number average diameter in the range of from 100 to 200 nm, may be used.
As defined herein, two layers are preferably in contact with one another by being bonded, adhered or laminated together.
In a special aspect, at least one of the layers of the membrane construction is coated. With 'coated' is meant that the at least one layer is contacted with a coating solution, such that the coating solution impregnates the layer. So, for example the nanoweb layer and/or the support layers and/or any other further layer of the membrane construction may be coated, or treated with antifouling e.g. PEG, proteins or amino acids. A coating may affects the porosity P and the thickness h of the support. Once coated, the membrane should pass the previous requirements in terms of pore size, porosity, thickness and weight per unit of surface.
Examples of coating solutions include antifouling coating solutions, for example antibiofouling coating solutions such as for example described in
WO2006/016800.
In a preferred embodiment at least one of the layers of the membrane
construction is coated with an antibiofouling coating. By coating at least one of the layers of the membrane construction with an antibiofouling coating, protein recovery in the blood plasma is increased. If the membrane construction is used for diagnostics, this will enhance the analysis resolution. If the membrane construction is used for dialysis, the efficiency of the dialysis will be increased. A description on how to impregnate a membrane layer is for example given in WO2009/063067.
In one aspect, the invention relates to a membrane cassette comprising the membrane construction of the invention.
With membrane cassette is meant a construction (housing) containing one or more membrane constructions of the invention.
In another aspect, the invention relates to a device comprising the membrane construction of or the membrane cassette of the invention.
Such devices may be devices used in plasma and serum separation in for example diagnostics; pre-analytical systems, such as blood collection devices, for example tubes and capillaries), micro fluidic point of care biosensor or Dry Plasma Spots.
The invention will now be elucidated with the following examples, without however being limited thereto.
Examples
The time to separate blood from plasma is measured with a card ridge test method described below. Cart ridge test method
A filter with a diameter of 10 mm is mounted on a card-ridge with a two-sided sticky tape (outer diameter 10 mm, inner diameter 8 mm). This card ridge is an injection moulded part comprising a filter mounting surface, a flow channel and a chamber R. The card ridge is horizontally positioned during the test.
Plasma that has passed the filter drops on a round flat surface with a diameter of 8 mm, comprising 6 grooves of each 0.15 mm width and 0.02 mm deep, separating the surface in 6 equal radial parts.
The center of said surface is connected with a channel with a length of 24 mm , a width of 0.6 mm and height of 0.08 mm. Via this channel, plasma that has passed the filter is guided to a chamber of 1 .6x1 .6 mm2 and a height of 0.08 mm.
Two drops of blood with a volume of 50 μΙ_ and a Hct% as given in Table 1 are applied with an Eppendorf pipette on the filter. The Start Time is the time wherein the first liquid has passed the first 4 mm in the channel. The Fill Time is the time wherein the chamber R is completely filled with plasma.
Comparative Experiments 1 - 7 were carried out with a Pall GF filter. The Pall GF filter is a filter made from polyethersulfone with a thickness of 340 μηη and a variable pore size ranging from 80 μηη to 3 μηη.
In the Comparative Experiments 8 -10 according WO201 1 151314 a Novatex support layer (non-woven PA66/PA6) with a thickness of 200 μηη and a PA nanoweb layer with a thickness of 10 μηη is used. The base weight of the layer of nanofibers is 2 g/m2.
The Examples I to VII according to the invention are based on a Lypore 9858 PEG microglass support layer with a base weight of 49.5 g/m2 (density 2.5 g/cm3) and a PA 46, 70 μηη thick layer of nanofibers with a base weight of 2 g/m2.
Table 1 .
From this table it can be learned that blood with more than 44 Hct % does pass the Pall filter, but does not reach the chamber This was due to blockage of the filter and subsequent hemolyse. Blood with more than ca. 30 Hct% does not even pass the comparative Novatex filter.
Claims
Membrane construction for the separation of blood cells from blood plasma, comprising multiple layers wherein
- at least of the layers is a support layer;
- at least one of the layers is a nanoweb made of polymeric nanofibers wherein the nanoweb comprises a mean flow pore size in the range from 0.3 to 3 μηι measured according to standard ASTM E 1294-89, a basis weight in the range 1 to 20 g/m2 measured according to standard ASTM D 3776 and a porosity in the range from 60 to 95 % measured according to standard ASTM D 2873-94 ; and
wherein the nanofibers have a number average diameter in the range from 100 to 600 nm measured by scanning electron microscopy; characterised in that the support layer is a porous layer with a mean flow pore size of between 5 and 15 μηι and h.P.A 100 is more than 5μΙ_, wherein h is the thickness of the support layer, P the porosity (%) of the support layer and A the surface of the support layer in the membrane construction.
Membrane construction according to claim 1 , wherein the mean flow pore size of the nanoweb is in the range 0.4 to 1.5 μηι.
Membrane construction according to claim 1 or 2, wherein the number average diameter of the nanofibers is in the range 200 to 300 nm.
Membrane construction according to claim any one of claims 1 to 3, wherein the polymeric nanofibers are polyamide nanofibers.
Membrane construction according to any one of claims 1 to 4, wherein h.P.A/100 is more than 15 μΙ_.
Membrane construction according to any one of claims 1 to 5, wherein h.P.A/100 calculated with a thickness h of about 250 μηι and a porosity P of at least 80%.
Membrane construction according to any one of claims 1 to 6, wherein the support layer is a non-woven layer based on micro-fibers with a number average diameter between 1 to 10 μηι.
Membrane construction according to any one of claims 1 to 7, wherein the support layer comprises micro-glass.
Membrane construction according to any one of claims 1 to 8, wherein the support layer is hydrophilic.
10. Membrane cassette for the separation of blood cells from blood plasma comprising the membrane construction of claim 1 -9.1 1 .
1 1. Device for the separation of blood cells from blood plasma, comprising the membrane construction of claim 1 -9, or the membrane cassette of claim 10.
12. Method for the filtration of blood comprising introducing blood through the
membrane construction according to any one of claims 1 to 9, or the membrane cassette according to claim 10, thereby separating blood cells from blood plasma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12198587 | 2012-12-20 | ||
EP12198587.3 | 2012-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014095959A1 true WO2014095959A1 (en) | 2014-06-26 |
Family
ID=47603074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/077030 WO2014095959A1 (en) | 2012-12-20 | 2013-12-18 | Membrane construction with fiber layers for blood filtration |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014095959A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3480293A4 (en) * | 2016-06-30 | 2019-07-03 | FUJIFILM Corporation | Cell-suspension membrane separation method and cell culture device |
CN110997305A (en) * | 2017-09-05 | 2020-04-10 | 四清空气公司 | Nanofiber webs with controllable solid phase volume fraction |
WO2021096426A1 (en) * | 2019-11-12 | 2021-05-20 | National University Of Singapore | A multi-layered membrane and a method of preparing the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048464A (en) * | 1995-12-26 | 2000-04-11 | Asahi Medical Co., Ltd. | Filter medium for leukocyte removal, method of making, and method of using thereof |
JP2004215873A (en) * | 2003-01-15 | 2004-08-05 | Kawasumi Lab Inc | Leukocyte removal filter |
WO2011151314A1 (en) * | 2010-06-03 | 2011-12-08 | Dsm Ip Assets B.V. | Membrane suitable for blood filtration |
-
2013
- 2013-12-18 WO PCT/EP2013/077030 patent/WO2014095959A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048464A (en) * | 1995-12-26 | 2000-04-11 | Asahi Medical Co., Ltd. | Filter medium for leukocyte removal, method of making, and method of using thereof |
JP2004215873A (en) * | 2003-01-15 | 2004-08-05 | Kawasumi Lab Inc | Leukocyte removal filter |
WO2011151314A1 (en) * | 2010-06-03 | 2011-12-08 | Dsm Ip Assets B.V. | Membrane suitable for blood filtration |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3480293A4 (en) * | 2016-06-30 | 2019-07-03 | FUJIFILM Corporation | Cell-suspension membrane separation method and cell culture device |
US11492578B2 (en) | 2016-06-30 | 2022-11-08 | Fujifilm Corporation | Membrane separation method of cell suspension, and cell culture device |
CN110997305A (en) * | 2017-09-05 | 2020-04-10 | 四清空气公司 | Nanofiber webs with controllable solid phase volume fraction |
EP3678860A4 (en) * | 2017-09-05 | 2021-10-13 | 4C Air, Inc. | Nanofiber web with controllable solid volume fraction |
CN110997305B (en) * | 2017-09-05 | 2023-01-24 | 四清空气公司 | Nanofiber webs with controllable solid phase volume fraction |
WO2021096426A1 (en) * | 2019-11-12 | 2021-05-20 | National University Of Singapore | A multi-layered membrane and a method of preparing the same |
CN114930145A (en) * | 2019-11-12 | 2022-08-19 | 新加坡国立大学 | Multilayer film and method for producing same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6704943B2 (en) | Nanofiber-containing composite structure | |
TWI517898B (en) | Membrane suitable for blood filtration | |
JP5802994B2 (en) | Nanofiber membrane layer for water and air filtration | |
KR101833336B1 (en) | Nanofiber containing composite structures | |
US8602223B2 (en) | High performance membrane | |
US9623352B2 (en) | Method for retrovirus removal | |
WO2015091181A2 (en) | Blood filtration | |
JP6050249B2 (en) | Filter media with high porosity and high basis weight | |
WO2014095959A1 (en) | Membrane construction with fiber layers for blood filtration | |
Islam et al. | THESIS EVALUATION | |
Islam | Fabrication of Various Nanofibrous Hybrid Membranes for Separation of Micro-Particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13811193 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13811193 Country of ref document: EP Kind code of ref document: A1 |